Natural antibody production can be inhibited by 15-deoxyspergualin in a discordant xenograft model.
作者信息
Flores H C, Leventhal J R, Gruber S A, Figueroa J, Platt J L, Manivel C, Bach F H, Matas A J, Bolman R M
机构信息
University of Minnesota Medical School, Minneapolis.
出版信息
Transplant Proc. 1992 Apr;24(2):714.
PMID:1566495
Abstract
摘要
相似文献
1
Natural antibody production can be inhibited by 15-deoxyspergualin in a discordant xenograft model.
Transplant Proc. 1992 Apr;24(2):714.
2
15-Deoxyspergualin and mouse to rat heart retransplantation.
Transplant Proc. 1992 Apr;24(2):710-1.
3
15-Deoxyspergualin inhibits antibody production in mouse to rat heart transplantation.
Transplant Proc. 1993 Feb;25(1 Pt 1):778-80.
4
5
Therapy with 15-deoxyspergualin and total lymphoid irradiation blocks xenograft rejection and antibody formation after xenografting.
Transplant Proc. 1991 Feb;23(1 Pt 1):210-1.
6
The effect of 15-deoxyspergualin on hamster-to-rat cardiac xenograft survival.
Transplant Proc. 1991 Feb;23(1 Pt 1):585-6.
7
Effects of leflunomide and deoxyspergualin in the guinea pig-->rat cardiac model of delayed xenograft rejection: suppression of B cell and C-C chemokine responses but not induction of macrophage lectin.
Transplantation. 1997 Sep 15;64(5):696-704. doi: 10.1097/00007890-199709150-00006.
8
Effect of 15-deoxyspergualin in islet xenograft rejection.
Transplant Proc. 1996 Jun;28(3):1426-7.
9
Effectiveness of combination therapy using cobra venom factor, splenectomy, and deoxyspergualin in guinea pig to rat cardiac xenografts.
Transplant Proc. 1993 Feb;25(1 Pt 1):405-6.
10
Mizoribine inhibits natural antibody production in a discordant xenograft model.
Transplant Proc. 1992 Apr;24(2):717.
引用本文的文献
1
Phase II study of deoxyspergualin in metastatic breast cancer.
Invest New Drugs. 1994;12(3):235-41. doi: 10.1007/BF00873965.
Zotero 插件